Metabolomic Diagnostics Ltd is an early stage medical diagnostics company dedicated to improving women’s health. The company’s focus is on developing innovative screening tests which can assess, long before the appearance of clinical symptoms, a woman’s risk of developing complications during pregnancy. This knowledge will create an opportunity for health care providers to engage in disease prevention and the timely provision of personalized care.
Since pregnancy and childbirth are key determinants of (future) health of women and their children, improving pregnancy care and pregnancy outcomes is the focus of Metabolomic Diagnostics.
Our Vision for Pregnancy
To use biomarkers to determine, early in a woman’s pregnancy, her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs.
Our Recipe for Success
In pursuing these goals, the company has become a world leader in translational biomarker research for preeclampsia and has developed exciting new tools to accelerate its work.